Which gliptin is marketed under the brand name Januvia?

Sitagliptin is marketed under the brand name Januvia, making it the correct choice. It belongs to a class of medications known as DPP-4 inhibitors, used primarily in the management of type 2 diabetes mellitus. These drugs work by increasing the levels of incretin hormones, which help to regulate glucose levels in the body, thereby improving glycemic control.

This medication is specifically designed to enhance insulin secretion in response to meals and decrease the amount of glucose produced by the liver. Januvia is often chosen for its favorable side effect profile and its effectiveness in lowering blood sugar levels. The recognition of this specific brand is important for understanding how it fits within diabetes management protocols.

Other gliptins listed, such as saxagliptin, linagliptin, and vildagliptin, are different medications from the same class but are marketed under different brand names. Each of these has its distinct characteristics and brand identifiers. Understanding the specific branding helps pharmacists and technicians provide accurate information and counseling to patients regarding their medications.